Collaborations with Patient Organisations
The pharmaceutical companies subject to the Code of Practice for the Pharmaceutical Industry publicly inform since 2009 of their collaborations with patient organisations. Additionally, since 2013, this information includes collaboration and service agreements. The name of the patient organisation, scope and nature of the collaboration, amount and services contracted are indicated.
Collaboration between pharmaceutical companies and patient organisations is recorded in writing, describing at least: activities to be carried out, level and sources of funding, purpose of said funding, relevant indirect support (ex.: free availability of their public relations agencies) and any other type of non-financial collaboration that may be relevant. Pharmaceutical companies shall establish a process to approve this type of collaborations prior to their taking place.